Skip to content
Derycz Scientific Featured In DDN (Drug Discovery News)
Company Chairman & CEO Peter Derycz Contributes Article Posted on DrugDiscoveryNews.com on January 10th
PRNewswire
SANTA MONICA, Calif.
(NASDAQ-OTCBB:DYSC)

SANTA MONICA, Calif., Jan. 11 /PRNewswire-FirstCall/ -- Derycz Scientific (OTCBulletinBoard: DYSC), a company that is pioneering a fresh way of facilitating the flow of information from content publishers to enterprise customers and their constituents, is featured in an article posted on January 10, 2010, on the website of DDN (Drug Discovery News). The article, written by Derycz Scientific Chairman & CEO Peter Derycz, is titled "Speeding the Path to FDA Approval in the Era of Electronic Submissions." It describes how a dedicated professional document preparation service, such as Derycz subsidiary Reprints Desk, Inc., can help streamline the process for pharmaceutical companies seeking to obtain market approval for a new drug from the U.S. Food and Drug Administration (FDA) and other regulatory agencies around the world.

In the article, Mr. Derycz notes that the FDA now requires all documentation linked with electronic submissions for drug approval to adhere to the electronic Common Technical Document (eCTD) format, an emerging global standard. This requirement poses distinct challenges for a pharmaceutical company because the standard scientific research articles that the company must submit to the FDA as part of the submission process must meet highly specific preparation requirements, and therefore need to be reformatted prior to submission. Reprints Desk, Inc. provides valuable aid in this regard, processing orders for specific research papers and delivering them to a client already formatted to required eCTD specifications.

"The advantages come clear to a pharmaceutical company sharing the eCTD challenge of regulatory submission with a scholarly document service [such as Reprints Desk]," writes Mr. Derycz in the article. "The best step you can take to speed your company's way through the regulatory approval process is to have your regulatory affairs personnel or contract research organization contact a supplier like Reprints Desk for a content workflow analysis to find a solution that will benefit you."

The article goes on to describe in detail the advantages of the eCTD format, the challenges it poses to pharmaceutical companies, and the benefits of engaging a company such as Reprints Desk to smooth the drug approval process.

The full article may be viewed online at: http://www.drugdiscoverynews.com/index.php?newsarticle=3541

About Derycz Scientific®

Derycz Scientific, Inc. (the "Company") develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Its subsidiary companies include Reprints Desk and Pools Press. Reprints Desk offers a one-stop solution for reprints, ePrints and single articles, and has delivered millions of articles worldwide. Reprints Desk is an innovator in content retrieval and ePrint delivery and its services are designed to help make effective use of published articles in a copyright-compliant manner. Pools Press has excelled in the reprint market for over 30 years. It provides professionally printed articles from medical and technical journals; prints booklets, catalogs, pamphlets, direct mail pieces, newsletters, and all business stationery; and works with publishers who wish to outsource a portion of or all of their reprints business. For more information, go to www.deryczscientific.com.

About Reprints Desk®

Reprints Desk, Inc. (www.reprintsdesk.com) is a business software and information services company that simplifies how research-intensive companies and other organizations procure, manage and share journal articles and other copyright-protected content. The company's content workflow and compliance solutions help customers effectively use peer-reviewed literature in research, regulatory submissions, and product promotions. A channel supplier for more than 100 scientific, technical, and medical (STM) publishers, Reprints Desk earned the #1 ranking in the 2008 Document Delivery Vendor Scorecard by Outsell, Inc., and currently serves companies in life sciences, energy, aerospace, industrial products, food and beverages, consumer packaged goods, information technology, and government. Reprints Desk is a Derycz Scientific (DYSC.OB) company. For more information about Reprints Desk, contact Ian Palmer at +1 (707) 658-1931.

SOURCE: Derycz Scientific, Inc.

Web site: http://www.deryczscientific.com/